Bayer may Sell Radiology Business


As it continues to pursue the acquisition of Monsanto for $62 billion, or possibly more, Germany’s Bayer is seen as potentially exploring a sale of its radiology supplies unit worth more than $3 billion.
Sources told the news agency Reuters that the Leverkusen-based group is in talks with investment banks about hiring a financial adviser to explore alternatives for the radiology supplies business, which generates more than €1.5 billion in revenue from contrast agents and related injection equipment. A sale was said to be one of the options.
Bayer picked up the radiology business in its 2006 acquisition of Berlin-based former pharmaceuticals and chemicals producer Schering. Products include Ultravist, a contrast medium for computer tomography with €318 million in 2015 sales, and Gadovist, a contrast medium for magnetic resonance imaging with sales of €290 million.
US media meanwhile reported last week that Monsanto had refused a presumably higher offer from Bayer, and that the German group has refused to bid even more for the agrochemicals giant unless the latter opens its books. Earlier, Bayer CEO Werner Baumann told a Deutsche Bank conference that talks were continuing in private.
According to the German news magazine Der Spiegel, Baumann’s predecessor at the Bayer helm, Marijn Dekkers, previously warned supervisory board chairman, Werner Wenning, against pursuing Monsanto.
Commenting on the M&A rounds in the agrochemical sector at a press conference of the German chemical industry association Verband der Chemischen Industrie (VCI ) early this year – before Bayer bid for Monsanto – Dekkers, who is still the association’s president, remarked that the two companies’ corporate cultures were not a good fit.
most read

Jens Birgersson Becomes New Brenntag CEO
Jens Birgersson becomes new Brenntag CEO

OQ Chemicals firmiert künftig wieder als Oxea
Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.

Sudarshan schließt Heubach-Übernahme ab
Sudarshan hat über seine hundertprozentige Tochtergesellschaft Sudarshan Europe die strategische Übernahme der Heubach-Gruppe abgeschlossen.

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.